glp 1 agonists drugs GLP-1 receptor are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Peptide Science GLP-1, GIP, and dual Medication:Tirzepatide (GLP-1 + GIP)

glp 1 agonists drugs GLP-1 receptor are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Peptide Science GLP-1, GIP, and dual Medication:Tirzepatide (GLP-1 + GIP)

GLP-1, GIP, and dual agonist medications are all part of the incretin class. But they are not interchangeable. GLP-1 receptor agonists like semaglutide reduce appetite, slow digestion, stimulate insulin, and suppress excess

Nature (2016) 537:50–6

Peptide Science

Medication:Tirzepatide (GLP-1 + GIP)

Retatrutide is a next level drug because it is a “triple agonist,” adding metabolic benefits to those provided by other drugs